United States · FDA National Drug Code directory
CLOZAPINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72603-913_61fe53d5-ed5c-4e45-9189-709d08d386cb
- Product NDC
- 72603-913
- Form
- TABLET
- Composition / generic term
- CLOZAPINE
- Labeler
- NorthStar Rx LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260801
- Source listing expiry
- 20271231
Source-listed ingredients
- CLOZAPINE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (72603-913-01) · 72603-913-01
- 500 TABLET in 1 BOTTLE (72603-913-02) · 72603-913-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →